Financials
- Market Capitalization 549.52 M
- Employee 115
- Founded 2019
- CEO N/A
- Website www.artivabio.com
- Headquarter Delaware, United States
- FIGI BBG00VPZJ0F9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.93
売上高対価格比率
593.22
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2829 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.90 USD | +0.53% | +11.11% | +23.38% | -8.65% | 574.41 M USD | ||
| 2834 | VALN Valneva SE - American Depositary Shares | 6.56 USD | +4.13% | -3.39% | +28.63% | -18.61% | 569.21 M USD | ||
| 2862 | CABA Cabaletta Bio, Inc. - Common Stock | 3.19 USD | +2.57% | -0.31% | +19.48% | +117.01% | 540.85 M USD | ||
| 2865 | OVID Ovid Therapeutics Inc. - Common Stock | 2.76 USD | +3.37% | -4.50% | +24.32% | +120.80% | 539.02 M USD |